Claim Missing Document
Check
Articles

Found 2 Documents
Search

Antifungal Activity Testing of Extract and Fractions from Tectona grandis Linn. F Leaves Using the Microdilution Method Anwar, Irvan -; Malina, Rachma -; Nuralifah, Nuralifah -; Parawansah, Parawansah -; U, Wa Ode Hartasyah
Indonesian Journal of Pharmaceutical Science and Technology 2024: Suppl. 6, No. 2 (Universitas Halu Uleo Conference)
Publisher : Indonesian Journal of Pharmaceutical Science and Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/ijpst.v6i2.52625

Abstract

Teak leaves (Tectona grandis Linn. F) are one of the plants that have empirically been used as antifungal, antioxidant, antibacterial, and antidiabetic agents, due to their content of secondary metabolite compounds including saponins, tannins, alkaloids, and sterols. This research aims to determine the secondary metabolite compounds present in the extract and fractions of teak leaves (Tectona grandis Linn. F) and the antifungal activity of the teak leaf extract and fractions against Candida albicans using the microdilution method. The ethanol extract was fractionated using a partition method with solvents n-hexane, chloroform, and ethyl acetate. Antifungal testing was carried out against Candida albicans using the Broth Microdilution method to measure the Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration (MFC) values. Based on the phytochemical screening results, teak leaves contain alkaloids, phenolics, flavonoids, and terpenoids. The MIC results for the antifungal activity of the ethanol extract, n-hexane fraction, chloroform fraction, and water fraction against Candida albicans were all >500 µg/mL. In the meantime, the MIC and MFC values for ketoconazole 200 mg against Candida albicans were 64 µg/mL. These results indicate that there is a difference in MIC and MFC values between the samples and the positive control (ketoconazole 200 mg), with the antifungal activity of the samples being weaker compared to the positive control
Measuring Compliance Therapy in Type 2 Diabetes Mellitus Patients using Proportion of Days Covered (PDC) Method and Its Effect on Clinical Outcomes Anwar, Irvan -; Sabarudin, Sabarudin; Malina, Rachma; Widaningsih, Ayu Dewi; Wijaya, Aurelia Arbaleta; Nurawaliah, Lilis
Pharmaceutical and Biomedical Sciences Journal (PBSJ) Vol. 6 No. 1 (2024)
Publisher : Pharmaceutical and Biomedical Sciences Journal (PBSJ)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.15408/pbsj.v6i1.37761

Abstract

Diabetes Mellitus (DM) is a chronic disease that occurs when blood glucose levels rise beyond normal limits because the body is unable to produce or use insulin effectively. Therapeutic adherence is one of the causes of normal blood glucose levels and the success of patient therapy. Measurement of therapeutic adherence of dm type 2 patients needs to be carried out to monitor the success of their therapy. This study aims to determine the adherence of antidiabetic therapy using the Proportion of Days Covered (PDC) method and its effect on the clinical outcomes of type 2 DM patients at Sulawesi Tenggara. The research method used is observational research with a descriptive design approach. The sample of this study was 186 people obtained using the Slovin formula. Patients are said to be adherence if their PDC value ≥ 80% and are said to be non-adherence if their PDC value < 80%. The data were analyzed using the chi square test. The results showed that patients adhering to treatment amounted to 130 people (69.9%), while patients who did not comply with treatment amounted to 56 people (30,1%) and there was a significant influence between adherence to antidiabetic therapy on the success of therapy  (clinical outcome) with p value = 0.000 in type 2 DM patients at Sulawesi Tenggara. It was be concluded that most of the patients in this study were adherent to the treatment and there was a significant influence between the adherence of antidiabetic therapy to the success of the therapy (clinical outcomes)